Recovery and Survival of EryDex in Non-patient Volunteers
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, single-blind, single-center, concurrently controlled, exploratory,
Phase I study to determine the in vivo kinetics (24-hour post-infusion recovery and T50
survival) of EryDex System (EDS) -processed autologous red blood cells (RBC) in non-patient
volunteers. A total of 12 non-patient volunteer subjects will be enrolled and assigned to one
of the 2 groups (6 subjects in active arm group, 6 subjects in sham arm group).